8-K: 3D Systems Narrows Q3 Loss, Forecasts Q4 Revenue Growth

3D Systems Corporation reported a significantly reduced net loss in the third quarter of 2025 and anticipates 8% to 10% sequential revenue growth in the fourth quarter.

Summary

• Reported Q3 2025 revenue of $91.2 million, a 19% decrease from $112.9 million in Q3 2024.
• Net loss attributable to 3D Systems Corporation improved significantly to $18.1 million in Q3 2025, compared to a loss of $178.6 million in Q3 2024.
• Diluted loss per share improved to $0.14 in Q3 2025 from $1.35 in Q3 2024.
• Adjusted EBITDA improved to a loss of $10.8 million in Q3 2025 from a loss of $14.3 million in Q3 2024.
• Operating expenses continued to decline, reflecting strong progress on cost reduction initiatives.
• Anticipates sequential top-line growth of 8% to 10% in Q4 2025, driven by new printer sales, increased materials consumption, and a rise in customer capital expenditures.
• Cash and cash equivalents decreased by $75.8 million since December 31, 2024, with $73.1 million used in operations and $98.3 million in financing activities over the nine months ended September 30, 2025.

Sentiment

Score: 6

Explanation: While the company reported a significant year-over-year improvement in net loss and Adjusted EBITDA, driven by effective cost reduction initiatives, revenue continued to decline. The positive outlook for sequential Q4 revenue growth and stabilization in key segments provides some optimism, but ongoing cash burn from operations and financing, coupled with persistent macroeconomic headwinds, temper the overall sentiment.

Positives

• Net loss significantly improved year-over-year, from $178.6 million in Q3 2024 to $18.1 million in Q3 2025.
• Adjusted EBITDA improved by $3.5 million to a loss of $10.8 million compared to the prior year period.
• Operating expenses continued to decline, reflecting strong progress on cost reduction initiatives.
• Anticipated sequential top-line growth of 8% to 10% in Q4 2025.
• Expected strengthening sales of new printer systems and increased materials consumption in Q4.
• Personalized health services expected to deliver strong growth in Q4 and double-digit growth for the full 2025 fiscal year.
• Dental business expected to stabilize with incremental growth from new denture product line.
• Cash provided by investing activities of $108.3 million for the nine months ended September 30, 2025, partially offsetting cash used in operations and financing.

Negatives

• Total revenue decreased 19% year-over-year to $91.2 million in Q3 2025.
• Healthcare Solutions revenue decreased 22% and Industrial Solutions revenue decreased 16% year-over-year.
• Gross profit margin decreased to 32.3% from 36.9% in the prior year period, primarily due to the divestiture of the Geomagic business and lower sales volume.
• Cash and cash equivalents decreased by $75.8 million since December 31, 2024.
• Cash used in operations was $73.1 million and cash used in financing activities was $98.3 million for the nine months ended September 30, 2025.
• Regenerative Medicine revenue declined sequentially.
• Heavier mix of printers puts pressure on gross margins in the short term.

Risks

• Macroeconomic conditions continue to impact customer capital expenditure spending.
• Extended duration of customer curtailment of capex spending.
• Tariff headwinds from rising printer sales putting pressure on gross margins.
• Uncertainties inherent in forward-looking statements, including known and unknown risks and other factors that may cause actual results to differ materially.

Future Outlook

Management anticipates sequential top-line revenue growth of 8% to 10% in the fourth quarter of 2025, driven by strengthening sales of new printer systems, increased materials consumption, and an expected rise in customer capital expenditures. This growth is projected across Healthcare, Industrial (aerospace and defense), and consumer markets. Personalized health services are expected to deliver strong Q4 growth and double-digit growth for the full fiscal year 2025, while the dental business is expected to stabilize with incremental growth from new denture products. Gross margins and operating expenses are expected to remain in line with current levels.

Management Comments

• "While the macroeconomic conditions remain similar to those of previous quarters, given the extended duration of our customers curtailment of capex spending, we are beginning to see improvements in our key end-markets as we enter the fourth quarter and approach year-end." Dr. Jeffrey Graves, President and CEO.
• "This, combined with our strong pipeline of new products, positions us well for improved sales, which we expect to increase sequentially by a range of 8% to 10% in the fourth quarter over those in the third quarter." Dr. Jeffrey Graves, President and CEO.
• "With our cost savings initiatives on track and markets showing signs of stabilization, we are increasingly optimistic about the future." Dr. Jeffrey Graves, President and CEO.
• "We remain focused on maintaining financial discipline, continuing to streamline our cost structure and strengthening our balance sheet. Our actions are designed to create a stronger financial foundation that will enable us to invest in future growth while delivering consistent results in a dynamic market environment." Phyllis Nordstrom, Interim Chief Financial Officer.

Industry Context

The company's performance reflects ongoing challenges from macroeconomic conditions and extended customer capital expenditure curtailment, a trend observed across various industrial sectors. However, the anticipated sequential growth in Q4, particularly in new printer systems and specific end-markets like aerospace, defense, and healthcare, suggests a potential stabilization or recovery in certain segments of the additive manufacturing industry. The focus on new product development and cost reduction initiatives aligns with broader industry efforts to navigate a dynamic market and position for future growth.

Management Changes

Stakeholder Impact

• Shareholders: Improved net loss and positive Q4 outlook could be favorable, but continued revenue decline and cash burn may raise concerns about long-term profitability and share dilution risk.
• Employees: Ongoing cost reduction initiatives suggest a focus on efficiency, which could impact workforce planning.
• Customers: Strengthening sales of new printer systems and increased materials consumption indicate continued engagement and demand for products, especially in healthcare and industrial markets.
• Creditors: The company has $122.6 million in debt, with $34.7 million maturing in Q4 2026, requiring careful financial management.

Next Steps

• Host a conference call and simultaneous webcast on November 5, 2025, at 8:30 a.m. Eastern Time to discuss Q3 2025 results.
• Continue to focus on maintaining financial discipline, streamlining cost structure, and strengthening the balance sheet.
• Invest in future growth while delivering consistent results.

Key Dates

Recommendation

While 3D Systems demonstrated significant improvement in its net loss and Adjusted EBITDA year-over-year, driven by effective cost controls, the continued decline in revenue remains a concern. The forecast for sequential Q4 revenue growth and stabilization in key markets offers a glimmer of optimism, suggesting the company may be turning a corner. However, the ongoing cash burn from operations and financing activities, coupled with persistent macroeconomic headwinds, indicates that a sustained recovery is not yet fully established. Investors should hold to observe if the anticipated Q4 growth materializes and if the company can achieve sustainable profitability and positive cash flow from operations.

Keywords

3D Systems, DDD, Q3 2025 Earnings, Financial Results, Additive Manufacturing, 3D Printing, Healthcare Solutions, Industrial Solutions, Revenue, Net Loss, Adjusted EBITDA, Cost Reduction, Capital Expenditures, SEC Filing, 8-K